Patent Reform in the News

Patent Reform in the News

The New York Post and The Washington Post have both run Op-eds in the last week addressing the need to reform the PTO’s inter partes review (IPR) process within current patent reform legislative efforts. Both opinions point to the weakness within the IPR process exposed by short selling practices of predatory hedge fund managers.

Click on the links below to read more:

From the New York Post:
Hedge-fund investors are coming to raid your medicine cabinet.
By Peter J. Pitts; former FDA associate commissioner, President of the Center for Medicine in the Public Interest

From The Washington Post:
Don’t let hedge funds undermine public health
By David Pyott; former chairman and CEO of Allergan

Filed under: Patently BIOtech, Public Policy, , , , , , ,